These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 19801858)
21. Evaluation of coprocessed disintegrants produced from tapioca starch and mannitol in orally disintegrating paracetamol tablet. Adeoye O; Alebiowu G Acta Pol Pharm; 2014; 71(5):803-11. PubMed ID: 25362809 [TBL] [Abstract][Full Text] [Related]
22. Formulation design of a novel fast-disintegrating tablet. Mizumoto T; Masuda Y; Yamamoto T; Yonemochi E; Terada K Int J Pharm; 2005 Dec; 306(1-2):83-90. PubMed ID: 16257154 [TBL] [Abstract][Full Text] [Related]
23. The effect of xylitol on the stability and morphological parameters of tablets with sorbitol made by direct tabletting of formulation components. Zgoda MM; Woskowicz M; Nachajski M; Haeusler O; Iwanczyk M Pharmazie; 2004 Aug; 59(8):651-3. PubMed ID: 15378860 [TBL] [Abstract][Full Text] [Related]
24. Quantification of γ-sorbitol crystal growth rate and solubility in the presence of mannitol and maltitol. DeJong AE; Hartel RW J Food Sci; 2020 Dec; 85(12):4319-4326. PubMed ID: 33175398 [TBL] [Abstract][Full Text] [Related]
25. Process optimization for continuous extrusion wet granulation. Tan L; Carella AJ; Ren Y; Lo JB Pharm Dev Technol; 2011 Aug; 16(4):302-15. PubMed ID: 20367553 [TBL] [Abstract][Full Text] [Related]
26. Development and Optimization of a Wet Granulation Process at Elevated Temperature for a Poorly Compactible Drug Using Twin Screw Extruder for Continuous Manufacturing. Meena AK; Desai D; Serajuddin AT J Pharm Sci; 2017 Feb; 106(2):589-600. PubMed ID: 27890244 [TBL] [Abstract][Full Text] [Related]
27. Investigating the fundamental effects of binders on pharmaceutical tablet performance. Joneja SK; Harcum WW; Skinner GW; Barnum PE; Guo JH Drug Dev Ind Pharm; 1999 Oct; 25(10):1129-35. PubMed ID: 10529894 [TBL] [Abstract][Full Text] [Related]
28. Preparation and evaluation of gelling granules to improve oral administration. Ito I; Ito A; Unezaki S Drug Discov Ther; 2015 Jun; 9(3):213-20. PubMed ID: 26193944 [TBL] [Abstract][Full Text] [Related]
29. Characterization, optimisation and process robustness of a co-processed mannitol for the development of orally disintegrating tablets. Soh JL; Grachet M; Whitlock M; Lukas T Pharm Dev Technol; 2013 Feb; 18(1):172-85. PubMed ID: 22582882 [TBL] [Abstract][Full Text] [Related]
31. A comparative study of the dissolution characteristics of capsule and tablet dosage forms of melt granulations of paracetamol--diluent effects. Uhumwangho MU; Okor RS Acta Pol Pharm; 2007; 64(1):73-9. PubMed ID: 17665854 [TBL] [Abstract][Full Text] [Related]
32. Roll compaction/dry granulation: Suitability of different binders. Mangal H; Kirsolak M; Kleinebudde P Int J Pharm; 2016 Apr; 503(1-2):213-9. PubMed ID: 26976499 [TBL] [Abstract][Full Text] [Related]
33. [Investigation of Oral Preparation That Is Expected to Improve Medication Administration: Preparation and Evaluation of Oral Gelling Tablet Using Sodium Alginate]. Ito I; Ito A; Unezaki S Yakugaku Zasshi; 2017; 137(8):969-977. PubMed ID: 28768950 [TBL] [Abstract][Full Text] [Related]
34. Formulation study for orally disintegrating tablet using partly pregelatinized starch binder. Mimura K; Kanada K; Uchida S; Yamada M; Namiki N Chem Pharm Bull (Tokyo); 2011; 59(8):959-64. PubMed ID: 21804239 [TBL] [Abstract][Full Text] [Related]
35. Formulation and evaluation of Cetirizine dihydrochloride orodispersible tablet. Subramanian S; Sankar V; Manakadan AA; Ismail S; Andhuvan G Pak J Pharm Sci; 2010 Apr; 23(2):232-5. PubMed ID: 20363705 [TBL] [Abstract][Full Text] [Related]
36. Influence of non-water-soluble placebo pellets of different sizes on the characteristics of orally disintegrating tablets manufactured by freeze-drying. Stange U; Führling C; Gieseler H J Pharm Sci; 2013 Jun; 102(6):1786-1799. PubMed ID: 23568590 [TBL] [Abstract][Full Text] [Related]
37. Direct compression and moulding properties of co-extruded isomalt/drug mixtures. Ndindayino F; Vervaet C; Van den Mooter G; Remon JP Int J Pharm; 2002 Mar; 235(1-2):159-68. PubMed ID: 11879751 [TBL] [Abstract][Full Text] [Related]
38. The role of formulation excipients in the development of lyophilised fast-disintegrating tablets. Chandrasekhar R; Hassan Z; Alhusban F; Smith AM; Mohammed AR Eur J Pharm Biopharm; 2009 May; 72(1):119-29. PubMed ID: 19073253 [TBL] [Abstract][Full Text] [Related]
39. Evaluation of rapidly disintegrating tablets manufactured by phase transition of sugar alcohols. Kuno Y; Kojima M; Ando S; Nakagami H J Control Release; 2005 Jun; 105(1-2):16-22. PubMed ID: 15955365 [TBL] [Abstract][Full Text] [Related]